Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H)
Csatary, L.K.; Moss, R.W.; Beuth, J.; Töröcsik, B.; Szeberenyi, J.; Bakacs, T.
Anticancer Research 19(1b): 635-638
1999
ISSN/ISBN: 0250-7005 PMID: 10216468 Document Number: 508114
Newcastle Disease Virus Vaccine (MTH-68/H) was administered to patients suffering from advanced neoplastic diseases after non-efficient tumor-destructive treatment. Case reports of selected patients suggest promising effects of this treatment. A prospectively-randomized clinical study (phase III; in accordance with Good Clinical Practice, GCP) was proposed to confirm these results and is currently under consideration.